Further, low SIRT6 expression predicted worse OS in head and neck cancer (P < 0.05) (Fig. 9G), urogenital cancer (P < 0.05) (Fig. 9I) and other system cancer (P < 0.05) (Fig. 9K). The gene discussed is SIRT6; the disease is urogenital neoplasm.